Estramustine

Links shared publicly online about this topic

Urology News & Articles - MDLinx - Prostatic Neoplasms Estramustine on #MDlinx

mdlinx.com — “Urology News & Articles - MDLinx - Prostatic Neoplasms Estramustine on #MDlinxView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on September 29, 2010 at 1:39 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

A phase 2 study of estramustine, docetaxel, and bevacizumab in men with castrate-resistant prostate cancer... http://bit.ly/c9rbNz #urology

2 years ago...

Oncology News & Articles - MDLinx - Prostatic Neoplasms Estramustine on #MDlinx

mdlinx.com — “Oncology News & Articles - MDLinx - Prostatic Neoplasms Estramustine on #MDlinxView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on September 29, 2010 at 7:41 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

A phase 2 study of estramustine, docetaxel, and bevacizumab in men with castrate-resistant prostate cance... http://bit.ly/dB50WY #oncology

2 years ago...

Oncology Medical News about Castration Prostate Prostatic Neoplasms

mdlinx.com — “A randomized phase II trial of personalized peptide vaccine plus low dose estramustine phosphate (EMP) versus standard dose EMP in patients with castration resistant prostate cancerView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on February 19, 2010 at 11:28 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Oncology A randomized phase II trial of personalized peptide vaccine plus low dose estramustine phosphate (EMP) ve... http://bit.ly/cDnMPx

2 years ago...

Combination chemotherapy with docetaxel, vinorelbi... [Anticancer Res. 2009] - PubMed result

ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 18 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.View full resource at ncbi.nlm.nih.gov

  • View Related
  • Share

Most Recently Shared on April 21, 2009 at 9:08 am By:

prostate_cancer prostate_cancer Health Organization

Combination chemotherapy with docetaxel, vinorelbine and estramustine phosphate in metastatic androgen-resistant... - http://bit.ly/9jm7O

3 years ago...

Personal Edition Locate

docguide.com — “Personal Edition LocateView full resource at docguide.com

  • View Related
  • Share

Most Recently Shared on March 8, 2010 at 12:24 am By:

prostatecancer_ Prostate Cancer Support

Docetaxel Plus Estramustine Can Improve Response in High-Risk Localised ... http://bit.ly/9renbP

2 years ago...

Prostatic Neoplasms on #MDlinx

mdlinx.com — “Prostatic Neoplasms on #MDlinxView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on October 22, 2010 at 5:36 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

A preclinical therapeutic schedule optimizing docetaxel plus estramustine administration in prostate cance... http://bit.ly/amRmPH #urology

2 years ago...

Urology Article | Carboplatin Prostatic Neoplasms

mdlinx.com — “Outcome, clinical prognostic factors and genetic predictors of adverse reactions of intermittent combination chemotherapy with docetaxel, estramustine phosphate and carboplatin for castration-resistant prostate cancerView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on July 18, 2011 at 9:46 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Outcome, clinical prognostic factors and genetic predictors of adverse reactions of intermittent combin... http://bit.ly/p3o1Bz #urology

10 months ago...

Oncology Article | Carboplatin Prostatic Neoplasms

mdlinx.com — “Outcome, clinical prognostic factors and genetic predictors of adverse reactions of intermittent combination chemotherapy with docetaxel, estramustine phosphate and carboplatin for castration-resistant prostate cancerView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on June 29, 2011 at 7:28 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Outcome, clinical prognostic factors and genetic predictors of adverse reactions of intermittent combi... http://bit.ly/mO87P5 #oncology

11 months ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

  • MDLinx

    Sandeep Pulim MD

    Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry

    View Profile

  • MDLinx

    Sandeep Pulim MD

    Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry

    View Profile

  • MDLinx

    Sandeep Pulim MD

    Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390